Technical Analysis for ESPR - Esperion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 50.08 -3.19% -1.65
ESPR closed down 3.19 percent on Monday, May 20, 2019, on 76 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical ESPR trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
New Uptrend Bullish -3.19%
NR7 Range Contraction -3.19%
Wide Bands Range Expansion -3.19%
Overbought Stochastic Strength -3.19%

Older signals for ESPR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
Biopharmaceutical Medical Specialties Diabetes Obesity Cardiology Cholesterol Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Lipids Lipoproteins Atherosclerosis
Is ESPR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 60.99
52 Week Low 35.8
Average Volume 663,047
200-Day Moving Average 46.4053
50-Day Moving Average 44.8644
20-Day Moving Average 46.775
10-Day Moving Average 49.99
Average True Range 2.2374
ADX 25.98
+DI 27.5608
-DI 13.1903
Chandelier Exit (Long, 3 ATRs ) 45.9878
Chandelier Exit (Short, 3 ATRs ) 45.7422
Upper Bollinger Band 53.8009
Lower Bollinger Band 39.7491
Percent B (%b) 0.74
BandWidth 30.041261
MACD Line 2.0207
MACD Signal Line 1.6077
MACD Histogram 0.413
Fundamentals Value
Market Cap 1.13 Billion
Num Shares 22.6 Million
EPS -5.77
Price-to-Earnings (P/E) Ratio -8.68
Price-to-Sales 0.00
Price-to-Book 6.37
PEG Ratio -4.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 54.39
Resistance 3 (R3) 54.78 53.74 53.67
Resistance 2 (R2) 53.74 52.64 53.54 53.43
Resistance 1 (R1) 51.91 51.97 51.39 51.52 53.19
Pivot Point 50.87 50.87 50.61 50.67 50.87
Support 1 (S1) 49.04 49.77 48.52 48.65 46.97
Support 2 (S2) 48.00 49.10 47.80 46.73
Support 3 (S3) 46.17 48.00 46.49
Support 4 (S4) 45.78